Comparison
Why is Bellevue Life Sciences Acquisition Corp. ?
- INTEREST(9M) At USD 0.1 MM has Grown at inf%
- NET PROFIT(HY) At USD -2.45 MM has Grown at -1,453.52%
- ROCE(HY) Lowest at -26.94%
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -94.88%, its profits have fallen by -281%
- Along with generating -94.88% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Finance)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Bellevue Life Sciences Acquisition Corp. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Fallen by -29.57% (YoY
Higher at USD 1.9 MM
Highest at 63.57%
Highest at 5.05%
Highest at USD 0.48 MM
Highest at USD 0.02
At USD 0.1 MM has Grown at inf%
At USD -2.45 MM has Grown at -1,453.52%
Lowest at -26.94%
Lowest at USD -5.08 MM
Lowest at USD -2.88 MM
Here's what is working for Bellevue Life Sciences Acquisition Corp.
Net Sales (USD MM)
Net Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Inventory Turnover Ratio
Debtors Turnover Ratio
Net Sales (USD MM)
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for Bellevue Life Sciences Acquisition Corp.
Interest Paid (USD MM)
Pre-Tax Profit (USD MM)
Pre-Tax Profit (USD MM)
Operating Profit (USD MM)






